Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
International Life Science Awards Recognize Reaxys
Posted on November 16th, 2020 by Xuanyan Xu in Chemistry
The International Life Sciences Awards, an initiative from Global Health & Pharma Magazine (GHP) that is now in its fifth year, recognizes industry innovators – and this year that has included honoring Reaxys as an innovation leader by awarding it the Best Chemistry Predictive Analytics Specialists 2020 for its best-in-class Predictive Retrosynthesis software.
GHP acknowledges the hard work and industry leadership from the Reaxys team in making an already powerful chemistry data solution even more so by developing an AI solution for drug discovery, noting that the Predictive Retrosynthesis software “combines reaction data with a deep learning algorithm to support innovation in synthetic and medicinal chemistry.”
In their profile of Reaxys, GHP highlights the incredible work of the Elsevier team in curating and verifying scientific knowledge, its groundbreaking partnerships with other innovators, and the company’s thirst to help develop new technologies. It was a collaboration with start-up Pending.AI (PAI) that yielded the Reaxys-PAI Predictive Retrosynthesis solution, and the tool is already being utilized by pharmaceutical and chemical companies for synthesis planning.
GHP also highlights the fact that Reaxys is helping organizations to digitalize by “enabling the extraction, curation and harmonization of chemistry data from companies’ electronic lab notebooks and combining it with published chemistry data.” This breaks down information silos and saves time by providing a single point to conduct searches. It also ensures the predictive retrosynthesis model is drawing from both published knowledge and a wealth of in-house research.
“With the recent outbreak of COVID-19 there is no better time to take our hats off to those who dedicate their professional lives to making our everyday lives safer,” said GHP about the International Life Science Awards. Reaxys is an important tool for all of drug discovery, but has certainly distinguished itself in the fight against COVID-19 this year. Elsevier has even offered complimentary access to it for researchers focusing on the coronavirus through our Coronavirus Research Hub.
“We are so pleased that the Reaxys team has been recognized as a leader in innovation by the International Life Sciences Awards for our work in retrosynthesis,” said Ivan Krstic, Director of Chemistry Solutions at Elsevier. “We will strive to continue making advances in this area that we hope will help drive amazing discoveries in drug research.”
Also visit our Coronavirus Research Hub to learn how researchers and data scientists can get access to valuable information.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Sr. Marketing Manager, Life Sciences Audience at Elsevier
- Elsevier and LG: Turning data into action
- Pharma can now track the most relevant patent info – fast and at scale
- Can predictive retrosynthesis become a valuable part of a chemist’s toolkit?
- AI-driven innovation in life sciences: Unlocking the page – 20+ years of digital innovation at Elsevier
- AI-driven innovation in life sciences: Data as data should be